Winton Group’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$925K Buy
+63,379
New +$612K 0.03% 529
2026
Q1
– Sell
-10,300
Closed -$121K – 1304
2025
Q4
$121K Buy
+10,300
New +$111K ﹤0.01% 868
2025
Q3
– Sell
-58,620
Closed -$429K – 933
2025
Q2
$429K Sell
58,620
-19,875
-25% -$160K 0.02% 622
2025
Q1
$745K Buy
+78,495
New +$980K 0.05% 469
2024
Q4
– Sell
-25,490
Closed -$376K – 732
2024
Q3
$376K Buy
+25,490
New +$399K 0.03% 480
2023
Q4
– Sell
-10,816
Closed -$133K – 825
2023
Q3
$133K Buy
+10,816
New +$161K 0.01% 702
2019
Q3
– Sell
-15,167
Closed -$333K – 1628
2019
Q2
$333K Sell
15,167
-14,985
-50% -$329K 0.01% 849
2019
Q1
$617K Buy
30,152
+878
+3% +$15.3K 0.01% 495
2018
Q4
$369K Buy
29,274
+3,744
+15% +$55.8K 0.01% 587
2018
Q3
$392K Buy
25,530
+4,866
+24% +$67.3K 0.01% 720
2018
Q2
$271K Sell
20,664
-20,772
-50% -$229K 0.01% 873
2018
Q1
$338K Buy
+41,436
New +$336K 0.01% 937

Other funds holding NEO

Winton Group's NEO Position: Q2 2026 in Review

Winton Group opened a new position in NeoGenomics (NEO) in Q2 2026: 63,379 shares worth $925K. The stake represents 0.03% of the portfolio and ranks #529 among its holdings. This is a return to the name: Winton Group previously reported a position in NEO as recently as Q4 2025.

Winton Group first reported a position in NEO in Q1 2018 and has held it in 12 quarters since. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Winton Group held 63,379 shares of NeoGenomics worth $925K as of Q2 2026.
  • NeoGenomics was a new Winton Group position in Q2 2026.
  • NeoGenomics made up 0.03% of Winton Group's portfolio in Q2 2026, its #529 holding.
  • Winton Group first reported a position in NeoGenomics in Q1 2018 and has held it in 12 quarters since.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.